Skip to main content
MyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed February 2026Updated July 2026

KLOW Blend Dosing Protocol — BPC-157, TB-500, KPV & GHK-Cu Guide

KLOW peptide blend (BPC-157 + TB-500 + KPV + GHK-Cu) dosing guide for tissue repair, anti-inflammatory support, and extracellular matrix remodeling — the GLOW blend plus KPV.

Go to peptide profileCalculate your dose

Quickstart highlights

The KLOW blend combines four peptides across complementary repair and immune pathways.

  • Four peptides: BPC-157 + TB-500 + KPV + GHK-Cu — the GLOW blend plus KPV.
  • BPC-157: nitric oxide + VEGF angiogenesis supporting tissue repair.
  • TB-500: actin-binding cell migration and wound closure.
  • KPV: alpha-MSH tripeptide — NF-kB suppression for anti-inflammatory activity.
  • GHK-Cu: matrix remodeling and collagen support; a blue-green solution color is normal.
  • Research-only: not FDA-approved; dosing is practitioner-reported, not from human trials.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-420010Once daily200 µg of each component — 10 units; starting dose
5-1250025Once daily500 µg each — 25 units; therapeutic dose for comprehensive anti-inflammatory skin and hair support

Your free KLOW Blend tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Create free account Already have one? Sign in

Reconstitution steps

  1. Reconstitute in the manufacturer-specified volume of bacteriostatic water for 2 mg/mL concentration.
  2. Swirl gently — GHK-Cu will produce the characteristic blue-green color.
  3. Label with date; refrigerate at 2–8 °C. Use within 28 days.

Supplies needed

12-week plan

  • 3 vials
  • 84 syringes
  • 15 mL bac water
  • 84 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Support tissue repair, damp inflammatory signaling, and aid extracellular matrix remodeling through the KLOW blend's combined angiogenic (BPC-157), cell-migration (TB-500), anti-inflammatory (KPV), and matrix-remodeling (GHK-Cu) mechanisms, administered via daily subcutaneous injection.

Cycle length: 12 weeks on.

Off-cycle: 8 weeks off; reassess recovery and inflammatory markers before resuming.

Storage & handling

Lyophilized: store below 25 °C. Reconstituted: refrigerate 2–8 °C; use within 28 days.

Injection & tracking tips

  • Inject subcutaneously in the abdomen or thigh; rotate sites to reduce injection-site irritation.
  • Reconstitute with bacteriostatic water and refrigerate; the blue-green tint from GHK-Cu is expected.
  • KLOW blend composition and ratios vary by supplier — confirm the four active peptides and concentrations before dosing.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Log the target recovery area and subjective pain or function (0–10) weekly.
  • Photograph any skin or wound area at baseline, 4 weeks, and 12 weeks under consistent lighting.
  • Consider hsCRP as a systemic inflammatory marker at baseline and 8 weeks.
Log your cycle in the calculator →

How this works & references

The KLOW blend combines four peptides across complementary repair and immune pathways. BPC-157 upregulates nitric oxide and VEGF-mediated angiogenesis for new capillary formation. TB-500 (a Thymosin Beta-4 fragment) binds G-actin to drive cell migration and wound closure. KPV (an alpha-MSH C-terminal tripeptide) suppresses NF-kB, lowering pro-inflammatory cytokine signaling (TNF-alpha, IL-1beta, IL-6). GHK-Cu regulates matrix metalloproteinase activity and redox balance, supporting collagen remodeling. It is effectively the GLOW blend (BPC-157 + TB-500 + GHK-Cu) with KPV added for extra anti-inflammatory coverage. None of the components is FDA-approved, and the combination has no published human trials.

Sources

  • Source: Sikiric P et al. — Stable gastric pentadecapeptide BPC 157. Curr Pharm Des. 2011. PMID: 21548867
  • Source: Goldstein AL, Hannappel E, Kleinman HK. — Thymosin beta4 and tissue repair. Trends Mol Med. 2005. PMID: 16099219
  • Source: Kannengiesser K et al. — KPV anti-inflammatory potential in IBD models. Inflamm Bowel Dis. 2008. PMID: 18092347
  • Source: Pickart L, Margolina A. — Regenerative actions of the GHK-Cu peptide. Int J Mol Sci. 2018. PMID: 29986520

Frequently asked questions

What is the difference between the KLOW and GLOW blends?
GLOW combines BPC-157, TB-500, and GHK-Cu. KLOW adds a fourth peptide, KPV — an alpha-MSH-derived tripeptide with NF-kB-suppressing anti-inflammatory activity. Both are research-only and unproven as combinations in humans.
What is a typical KLOW blend dose?
Practitioner-reported dosing is roughly 200–500 mcg of each component once daily by subcutaneous injection. These figures are not validated by human clinical trials — discuss any protocol with a licensed provider.
Is the KLOW blend FDA approved?
No. All four components — BPC-157, TB-500, KPV, and GHK-Cu — are research-only. BPC-157 was removed from the FDA 503A bulk drug substance list in 2023, and the combination has no legal commercial pathway in the US.
What is the KLOW blend studied for?
Tissue repair, anti-inflammatory support, and extracellular matrix remodeling — combining BPC-157 angiogenesis, TB-500 cell migration, KPV NF-kB suppression, and GHK-Cu collagen and matrix effects. The evidence is preclinical; no human combination trials exist.
How is the KLOW blend reconstituted and stored?
Reconstitute with bacteriostatic water to the supplier-specified concentration (commonly about 2 mg/mL), swirl gently (a blue-green color from GHK-Cu is normal), refrigerate at 2–8 °C, and use within about 28 days.

Related protocols

GLOW Blend Dosing Protocol — BPC-157, TB-500 & GHK-Cu Skin & Repair Guide

GLOW peptide blend (BPC-157 + TB-500 + GHK-Cu) dosing guide for tissue repair, angiogenesis, and collagen and connective-tissue remodeling.

View protocol

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.

View protocol

Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide

Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.

View protocol

Testagen Dosing Protocol: 20 mg Vial — Testicular Bioregulator & Testosterone Support Guide

Testagen (Lys-Glu-Asp-Gly tetrapeptide) Russian testicular bioregulator dosing guide — Leydig cell gene normalization for testosterone production optimization and male reproductive aging support.

View protocol

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Need help?

Browse vetted clinicsView full peptide profile →